Sartorius Stedim Biotech (FR:DIM) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Sartorius Stedim Biotech has issued a declaration regarding its share capital and voting rights as of June 30, 2024, disclosing a total of 97,330,405 shares and 165,528,510 net voting rights.
For further insights into FR:DIM stock, check out TipRanks’ Stock Analysis page.